Annual Cash & Cash Equivalents
$15.40 K
-$109.10 K-87.63%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual cash & cash equivalents is currently $15.40 thousand, with the most recent change of -$109.10 thousand (-87.63%) on 31 December 2023. During the last 3 years, it has risen by +$10.60 thousand (+220.83%). BLACU annual cash & cash equivalents is now -87.63% below its all-time high of $124.50 thousand, reached on 31 December 2022.BLACU Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$12.20 K
-$106.90 K-89.76%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly cash and cash equivalents is currently $12.20 thousand, with the most recent change of -$106.90 thousand (-89.76%) on 30 September 2024. Over the past year, it has dropped by -$3200.00 (-20.78%). BLACU quarterly cash and cash equivalents is now -96.50% below its all-time high of $348.80 thousand, reached on 01 March 2023.BLACU Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -20.8% |
| 3 y3 years | +220.8% | +154.2% |
| 5 y5 years | - | - |
BLACU Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -87.6% | +220.8% | -96.5% | +916.7% |
| 5 y | 5 years | -87.6% | +220.8% | -96.5% | +916.7% |
| alltime | all time | -87.6% | +220.8% | -96.5% | +916.7% |
Bellevue Life Sciences Acquisit Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.20 K(-89.8%) |
| June 2024 | - | $119.10 K(+3208.3%) |
| Mar 2024 | - | $3600.00(-76.6%) |
| Dec 2023 | $15.40 K | $15.40 K(-73.4%) |
| Sept 2023 | - | $58.00 K(+4733.3%) |
| June 2023 | - | $1200.00(-99.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $348.80 K(+180.2%) |
| Dec 2022 | $124.50 K(+2493.8%) | - |
| Dec 2022 | - | $124.50 K(+81.0%) |
| Sept 2022 | - | $68.80 K(-7.3%) |
| June 2022 | - | $74.20 K(+1445.8%) |
| Dec 2021 | $4800.00(-92.3%) | $4800.00 |
| Dec 2020 | $62.70 K | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly cash and cash equivalents year-on-year change?
What is Bellevue Life Sciences Acquisit annual cash & cash equivalents?
The current annual cash & cash equivalents of BLACU is $15.40 K
What is the all time high annual cash & cash equivalents for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual cash & cash equivalents is $124.50 K
What is Bellevue Life Sciences Acquisit quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLACU is $12.20 K
What is the all time high quarterly cash and cash equivalents for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly cash and cash equivalents is $348.80 K
What is Bellevue Life Sciences Acquisit quarterly cash and cash equivalents year-on-year change?
Over the past year, BLACU quarterly cash and cash equivalents has changed by -$3200.00 (-20.78%)